ISOLA, MIRIAM
 Distribuzione geografica
Continente #
NA - Nord America 592
AS - Asia 132
EU - Europa 127
AF - Africa 4
SA - Sud America 4
OC - Oceania 1
Totale 860
Nazione #
US - Stati Uniti d'America 591
SG - Singapore 65
SE - Svezia 46
HK - Hong Kong 24
IT - Italia 20
CN - Cina 16
CH - Svizzera 13
KR - Corea 13
BG - Bulgaria 11
IE - Irlanda 10
BE - Belgio 9
DE - Germania 7
IN - India 6
FI - Finlandia 5
TW - Taiwan 4
UA - Ucraina 4
BR - Brasile 3
SN - Senegal 3
AR - Argentina 1
AU - Australia 1
CA - Canada 1
ES - Italia 1
GB - Regno Unito 1
IL - Israele 1
IR - Iran 1
PH - Filippine 1
TN - Tunisia 1
TR - Turchia 1
Totale 860
Città #
Fairfield 96
Singapore 60
Ashburn 57
Woodbridge 51
Seattle 46
Chandler 42
Houston 38
Wilmington 36
Ann Arbor 31
Cambridge 26
Hong Kong 24
Princeton 18
Boardman 13
Seoul 13
Sofia 11
Bern 10
Dublin 10
Santa Clara 10
Brussels 9
Jacksonville 8
Trieste 8
San Diego 7
Beijing 5
Pune 5
Zhongli District 4
Dakar 3
Helsinki 3
Norwalk 3
Shanghai 3
Tolmezzo 3
Zurich 3
Bremen 2
Hefei 2
Lappeenranta 2
Messina 2
São Paulo 2
Vibo Valentia 2
Washington 2
Andover 1
Binangonan 1
Chongqing 1
Council Bluffs 1
Dallas 1
Guaratingueta 1
Haifa 1
Istanbul 1
Los Angeles 1
Mumbai 1
Redwood City 1
Tehran 1
Toronto 1
Udine 1
Totale 684
Nome #
Low-dose rituximab in adult patients with primary immune thrombocytopenia 120
Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia 96
Prognostic significance of delayed thrombocytopenia after allogeneic stem cell transplant 92
Bendamustine in chronic lymphocytic leukemia: Outcome according to different clinical and biological prognostic factors in the everyday clinical practice 90
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia 90
Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long-term response 87
Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results 87
Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura 69
Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients 52
Predicting lymphoma in Sjögren's syndrome and the pathogenetic role of parotid microenvironment through precise parotid swelling recording 33
Inter-reader agreement of the Prostate Imaging Quality (PI-QUAL) score: A bicentric study 31
Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab 29
Ventilatory associated barotrauma in COVID-19 patients: A multicenter observational case control study (COVI-MIX-study) 21
Intravitreal injections: a healthcare failure modes and effects analysis 17
Totale 914
Categoria #
all - tutte 3.858
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.858


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020191 0 0 0 0 13 35 43 31 34 16 4 15
2020/2021162 2 19 4 25 19 23 8 13 4 17 6 22
2021/2022122 5 13 0 4 1 1 8 3 26 10 8 43
2022/2023176 12 17 18 12 19 31 0 17 30 8 11 1
2023/2024153 14 13 11 6 17 26 19 14 13 1 18 1
2024/2025110 3 44 55 8 0 0 0 0 0 0 0 0
Totale 914